Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2014

01.05.2014 | Epidemiology

Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies

verfasst von: Amy Trentham-Dietz, Brian L. Sprague, John M. Hampton, Diana L. Miglioretti, Heidi D. Nelson, Linda J. Titus, Kathleen M. Egan, Patrick L. Remington, Polly A. Newcomb

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

While several risk factors for breast cancer have been identified, studies have not consistently shown whether these factors operate more strongly at certain ages or for just pre- or postmenopausal women. We evaluated whether risk factors for breast cancer differ according to age or menopausal status. Data from five population-based case–control studies conducted during 1988–2008 were combined and analyzed. Cases (N = 23,959) and population controls (N = 28,304) completed telephone interviews. Logistic regression was used to estimate adjusted odds ratios and 95 % confidence intervals and tests for interaction by age and menopausal status. Odds ratios for first-degree family history of breast cancer were strongest for younger women—reaching twofold elevations—but were still statistically significantly elevated by 58–69 % among older women. Obesity was inversely associated with breast cancer among younger women and positively associated with risk for older women (interaction P < 0.0001). Recent alcohol intake was more strongly related to breast cancer risk among older women, although consumption of 3 or more drinks/day among younger women also was associated with elevated odd ratios (P < 0.0001). Associations with benign breast disease and most reproductive/menstrual factors did not vary by age. Repeating analysis stratifying by menopausal status produced similar results. With few exceptions, menstrual and lifestyle factors are associated with breast cancer risk regardless of age or menopausal status. Variation in the association of family history, obesity, and alcohol use with breast cancer risk by age and menopausal status may need to be considered when determining individual risk for breast cancer.
Literatur
1.
Zurück zum Zitat Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713–1727 Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713–1727
2.
Zurück zum Zitat Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558–1568 Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558–1568
3.
Zurück zum Zitat Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76:27–36PubMedCrossRef Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76:27–36PubMedCrossRef
4.
Zurück zum Zitat Anderson WF, Chen BE, Brinton LA, Devesa SS (2007) Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 18:1187–1198. doi:10.1007/s10552-007-9057-x PubMedCrossRef Anderson WF, Chen BE, Brinton LA, Devesa SS (2007) Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 18:1187–1198. doi:10.​1007/​s10552-007-9057-x PubMedCrossRef
5.
Zurück zum Zitat Andrieu N, Prevost T, Rohan TE, Luporsi E, Le MG, Gerber M, Zaridze DG, Lifanova Y, Renaud R, Lee HP, Duffy SW (2000) Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol 29:214–223PubMedCrossRef Andrieu N, Prevost T, Rohan TE, Luporsi E, Le MG, Gerber M, Zaridze DG, Lifanova Y, Renaud R, Lee HP, Duffy SW (2000) Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol 29:214–223PubMedCrossRef
6.
Zurück zum Zitat Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. New Engl J Med 356:227–236. doi:10.1056/NEJMoa062790 PubMedCrossRef Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. New Engl J Med 356:227–236. doi:10.​1056/​NEJMoa062790 PubMedCrossRef
8.
Zurück zum Zitat Byrne C, Brinton LA, Haile RW, Schairer C (1991) Heterogeneity of the effect of family history on breast cancer risk. Epidemiology 2:276–284PubMedCrossRef Byrne C, Brinton LA, Haile RW, Schairer C (1991) Heterogeneity of the effect of family history on breast cancer risk. Epidemiology 2:276–284PubMedCrossRef
9.
Zurück zum Zitat Calle EE, Martin LM, Thun MJ, Miracle HL, Heath CW Jr (1993) Family history, age, and risk of fatal breast cancer. Am J Epidemiol 138:675–681PubMed Calle EE, Martin LM, Thun MJ, Miracle HL, Heath CW Jr (1993) Family history, age, and risk of fatal breast cancer. Am J Epidemiol 138:675–681PubMed
10.
Zurück zum Zitat Chie W-C, Hsieh C–C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151:715–722PubMedCrossRef Chie W-C, Hsieh C–C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151:715–722PubMedCrossRef
12.
Zurück zum Zitat Claus EB, Risch NJ, Thompson WD (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961–972PubMed Claus EB, Risch NJ, Thompson WD (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961–972PubMed
13.
Zurück zum Zitat Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol 152:950–964PubMedCrossRef Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol 152:950–964PubMedCrossRef
14.
Zurück zum Zitat Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187–195. doi:10.1016/S0140-6736(02)09454-0 CrossRef Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187–195. doi:10.​1016/​S0140-6736(02)09454-0 CrossRef
15.
Zurück zum Zitat Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR (2001) Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710–715PubMedCrossRef Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR (2001) Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710–715PubMedCrossRef
16.
Zurück zum Zitat Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC (1998) Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomark Prev 7:359–364 Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC (1998) Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomark Prev 7:359–364
17.
Zurück zum Zitat Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman AJ, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, Johnson KC, Mao Y, De Sanjose S, Lee N, Marchbanks P, Ory HW, Peterson HB, Wilson HG, Wingo PA, Ebeling K, Kunde D, Nishan P, Hopper JL, Colditz G, Gajalanski V, Martin N, Pardthaisong T, Silpisornkosol S, Theetranont C, Boosiri B, Chutivongse S, Jimakorn P, Virutamasen P, Wongsrichanalai C, Ewertz M, Adami HO, Bergkvist L, Magnusson C, Persson I, Chang-Claude J, Paul C, Skegg DC, Spears GF, Boyle P, Evstifeeva T, Daling JR, Hutchinson WB, Malone K, Noonan EA, Stanford JL, Thomas DB, Weiss NS, White E, Andrieu N, Bremond A, Clavel F, Gairard B, Lansac J, Piana L, Renaud R, Izquierdo A, Viladiu P, Cuevas HR, Ontiveros P, Palet A, Salazar SB, Aristizabel N, Cuadros A, Tryggvadottir L, Tulinius H, Bachelot A, Le MG, Peto J, Franceschi S, Lubin F, Modan B, Ron E, Wax Y, Friedman GD, Hiatt RA, Levi F, Bishop T, Kosmelj K et al (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87:1234–1245PubMedCrossRef Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman AJ, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, Johnson KC, Mao Y, De Sanjose S, Lee N, Marchbanks P, Ory HW, Peterson HB, Wilson HG, Wingo PA, Ebeling K, Kunde D, Nishan P, Hopper JL, Colditz G, Gajalanski V, Martin N, Pardthaisong T, Silpisornkosol S, Theetranont C, Boosiri B, Chutivongse S, Jimakorn P, Virutamasen P, Wongsrichanalai C, Ewertz M, Adami HO, Bergkvist L, Magnusson C, Persson I, Chang-Claude J, Paul C, Skegg DC, Spears GF, Boyle P, Evstifeeva T, Daling JR, Hutchinson WB, Malone K, Noonan EA, Stanford JL, Thomas DB, Weiss NS, White E, Andrieu N, Bremond A, Clavel F, Gairard B, Lansac J, Piana L, Renaud R, Izquierdo A, Viladiu P, Cuevas HR, Ontiveros P, Palet A, Salazar SB, Aristizabel N, Cuadros A, Tryggvadottir L, Tulinius H, Bachelot A, Le MG, Peto J, Franceschi S, Lubin F, Modan B, Ron E, Wax Y, Friedman GD, Hiatt RA, Levi F, Bishop T, Kosmelj K et al (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87:1234–1245PubMedCrossRef
18.
Zurück zum Zitat Hankinson S, Tamimi R, Hunter D (2008) Breast Cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 403–445CrossRef Hankinson S, Tamimi R, Hunter D (2008) Breast Cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 403–445CrossRef
19.
Zurück zum Zitat Jacobsen BK, Heuch I, Kvale G (2003) Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 157:923–929PubMedCrossRef Jacobsen BK, Heuch I, Kvale G (2003) Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 157:923–929PubMedCrossRef
20.
Zurück zum Zitat Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A (1998) Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51:1271–1276PubMedCrossRef Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A (1998) Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51:1271–1276PubMedCrossRef
21.
Zurück zum Zitat Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, Davies DS, Elliott P (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:759–770. doi:10.1007/s10552-006-0011-0 PubMedCrossRef Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, Davies DS, Elliott P (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:759–770. doi:10.​1007/​s10552-006-0011-0 PubMedCrossRef
22.
Zurück zum Zitat Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226PubMedCrossRef Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226PubMedCrossRef
23.
Zurück zum Zitat Kruk J (2007) Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case–control study in the Region of Western Pomerania (Poland). Asian Pac J Cancer Prev 8:513–524PubMed Kruk J (2007) Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case–control study in the Region of Western Pomerania (Poland). Asian Pac J Cancer Prev 8:513–524PubMed
25.
Zurück zum Zitat Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef
26.
Zurück zum Zitat Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102:1422–1431. doi:10.1093/jnci/djq316 PubMedCentralPubMedCrossRef Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102:1422–1431. doi:10.​1093/​jnci/​djq316 PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Longnecker MP (1994) Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73–82PubMedCrossRef Longnecker MP (1994) Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73–82PubMedCrossRef
28.
Zurück zum Zitat Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER, Clapp RW, Bogdan G, Willett WC, MacMahon B (1992) The reliability of self-reported alcohol consumption in the remote past. Epidemiology 3:535–539PubMedCrossRef Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER, Clapp RW, Bogdan G, Willett WC, MacMahon B (1992) The reliability of self-reported alcohol consumption in the remote past. Epidemiology 3:535–539PubMedCrossRef
29.
Zurück zum Zitat Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni JF Jr (1982) Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst 68:211–217PubMed Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni JF Jr (1982) Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst 68:211–217PubMed
30.
Zurück zum Zitat Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A (2014) Body mass index and breast cancer risk according to postmenopausal estrogen–progestin use and hormone receptor status. Epidemiol Rev 36:114–136. doi:10.1093/epirev/mxt010 PubMedCrossRef Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A (2014) Body mass index and breast cancer risk according to postmenopausal estrogen–progestin use and hormone receptor status. Epidemiol Rev 36:114–136. doi:10.​1093/​epirev/​mxt010 PubMedCrossRef
31.
Zurück zum Zitat Nelson SE, Gould MN, Hampton JM, Trentham-Dietz A (2005) A case–control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res 7:R357–R364PubMedCentralPubMedCrossRef Nelson SE, Gould MN, Hampton JM, Trentham-Dietz A (2005) A case–control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res 7:R357–R364PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Newcomb PA, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Greenberg ER, Baron JA, Willett WC, Stampfer MJ (1999) Lactation in relation to postmenopausal breast cancer. Am J Epidemiol 150:174–182PubMedCrossRef Newcomb PA, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Greenberg ER, Baron JA, Willett WC, Stampfer MJ (1999) Lactation in relation to postmenopausal breast cancer. Am J Epidemiol 150:174–182PubMedCrossRef
33.
Zurück zum Zitat Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron JA, Clapp RW, Bogdan G, Willett WC (1995) Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142:788–795PubMed Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron JA, Clapp RW, Bogdan G, Willett WC (1995) Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142:788–795PubMed
34.
Zurück zum Zitat Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Willett WC, MacMahon B (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330:81–87PubMedCrossRef Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Willett WC, MacMahon B (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330:81–87PubMedCrossRef
36.
Zurück zum Zitat Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14:225–233PubMedCrossRef Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14:225–233PubMedCrossRef
37.
Zurück zum Zitat Newcomer LM, Newcomb PA, Trentham-Dietz A, Longnecker MP, Greenberg ER (2003) Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer 106:961–964PubMedCrossRef Newcomer LM, Newcomb PA, Trentham-Dietz A, Longnecker MP, Greenberg ER (2003) Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer 106:961–964PubMedCrossRef
38.
Zurück zum Zitat Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willett WC, Newcomb PA (2006) From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol 164:1003–1011PubMedCrossRef Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willett WC, Newcomb PA (2006) From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol 164:1003–1011PubMedCrossRef
39.
Zurück zum Zitat Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ (1986) Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 37:21–25PubMedCrossRef Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ (1986) Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 37:21–25PubMedCrossRef
42.
Zurück zum Zitat Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI (2011) Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomark Prev 20:454–463. doi:10.1158/1055-9965.EPI-10-0974 CrossRef Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI (2011) Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomark Prev 20:454–463. doi:10.​1158/​1055-9965.​EPI-10-0974 CrossRef
45.
Zurück zum Zitat Roseman DL, Straus AK, Shorey W (1990) A positive family history of breast cancer. Does it effect diminish with age? Arch Intern Med 150:191–194PubMedCrossRef Roseman DL, Straus AK, Shorey W (1990) A positive family history of breast cancer. Does it effect diminish with age? Arch Intern Med 150:191–194PubMedCrossRef
46.
Zurück zum Zitat Rosenberg L, Metzger LS, Palmer JR (1993) Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 15:133–144PubMed Rosenberg L, Metzger LS, Palmer JR (1993) Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 15:133–144PubMed
47.
Zurück zum Zitat Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333PubMedCrossRef Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333PubMedCrossRef
48.
Zurück zum Zitat Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279:535–540PubMedCrossRef Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279:535–540PubMedCrossRef
49.
Zurück zum Zitat Sowers MR, La Pietra MT (1995) Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 17:287–302PubMed Sowers MR, La Pietra MT (1995) Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 17:287–302PubMed
50.
Zurück zum Zitat Sprague BL, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Remington PL, Newcomb PA (2011) Variation in breast cancer risk factors by mode of detection. Am J Epidemiol 173:S251 Sprague BL, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Remington PL, Newcomb PA (2011) Variation in breast cancer risk factors by mode of detection. Am J Epidemiol 173:S251
51.
Zurück zum Zitat Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM (2007) Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomark Prev 16:236–243CrossRef Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM (2007) Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomark Prev 16:236–243CrossRef
52.
Zurück zum Zitat Surveillance Epidemiology and End Results (SEER) Program (April 2011 (updated 10/28/2011), based on the November 2010 submission) SEER*Stat Database: Incidence—SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008) <Katrina/Rita Population Adjustment>-Linked to County Attributes—Total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch Surveillance Epidemiology and End Results (SEER) Program (April 2011 (updated 10/28/2011), based on the November 2010 submission) SEER*Stat Database: Incidence—SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008) <Katrina/Rita Population Adjustment>-Linked to County Attributes—Total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch
53.
Zurück zum Zitat Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis of epidemiological studies. Int J Cancer 122:1832–1841. doi:10.1002/ijc.23184 PubMedCrossRef Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis of epidemiological studies. Int J Cancer 122:1832–1841. doi:10.​1002/​ijc.​23184 PubMedCrossRef
54.
Zurück zum Zitat Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer 124:698–712. doi:10.1002/ijc.23943 PubMedCrossRef Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer 124:698–712. doi:10.​1002/​ijc.​23943 PubMedCrossRef
55.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron JA, Greenberg ER, Willett WC (1997) Body size and risk of breast cancer. Am J Epidemiol 145:1011–1019PubMedCrossRef Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron JA, Greenberg ER, Willett WC (1997) Body size and risk of breast cancer. Am J Epidemiol 145:1011–1019PubMedCrossRef
56.
Zurück zum Zitat WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consulation. In: WHO Technical Report Series 894. World Health Organization, Geneva WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consulation. In: WHO Technical Report Series 894. World Health Organization, Geneva
57.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2007) 7.10 Breast Cancer. In: Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC, pp. 289–295 World Cancer Research Fund/American Institute for Cancer Research (2007) 7.10 Breast Cancer. In: Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC, pp. 289–295
58.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
Metadaten
Titel
Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies
verfasst von
Amy Trentham-Dietz
Brian L. Sprague
John M. Hampton
Diana L. Miglioretti
Heidi D. Nelson
Linda J. Titus
Kathleen M. Egan
Patrick L. Remington
Polly A. Newcomb
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2905-y

Weitere Artikel der Ausgabe 1/2014

Breast Cancer Research and Treatment 1/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.